Back
Summit Therapeutics Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
60
SMMT
Summit Therapeutics
Last Price:
19.00
Seasonality Move:
33.32%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SMMT is experiencing slight buying pressure.
Summit Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.03 | Sell |
| 20-day SMA: | 19.94 | Sell |
| 50-day SMA: | 21.09 | Sell |
| 200-day SMA: | 10.73 | Buy |
| 8-day EMA: | 19.2 | Sell |
| 20-day EMA: | 19.73 | Sell |
| 50-day EMA: | 19.28 | Sell |
| 200-day EMA: | 12.7 | Buy |
Summit Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.38 | Sell |
| Relative Strength Index (14 RSI): | 46.02 | Sell |
| Chaikin Money Flow: | 95806 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.87 - 21.19) | Sell |
| Bollinger Bands (100): | (10.66 - 22.14) | Buy |
Summit Therapeutics Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Summit Therapeutics Stock
Is Summit Therapeutics Stock a Buy?
- Summit Therapeutics share price is 19.00 while SMMT 8-day simple moving average is 19.03, which is a Sell signal.
- The stock price of SMMT is 19.00 while Summit Therapeutics 20-day SMA is 19.94, which makes it a Sell.
- Summit Therapeutics 50-day simple moving average is 21.09 while SMMT share price is 19.00, making it a Sell technically.
- SMMT stock price is 19.00 and Summit Therapeutics 200-day simple moving average is 10.73, creating a Buy signal.
SMMT Technical Analysis vs Fundamental Analysis
Buy
60
Summit Therapeutics (SMMT)
is a Buy
Is Summit Therapeutics a Buy or a Sell?
-
Summit Therapeutics stock is rated a Buy
The current Summit Therapeutics [SMMT] share price is $19.00. The Score for SMMT is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
Summit Therapeutics Stock Info
Market Cap:
14.01B
Price in USD:
19.00
Share Volume:
1.5M
Summit Therapeutics 52-Week Range
52-Week High:
33.89
52-Week Low:
1.89
Buy
60
Summit Therapeutics (SMMT)
is a Buy
Summit Therapeutics Share Price Forecast
-
What is the Summit Therapeutics stock price today?
The Summit Therapeutics stock price is 19.00 USD today. -
Will SMMT stock go up or go down?
Summit Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Summit Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Summit Therapeutics is not overvalued.
Is Summit Therapeutics Stock a Buy?
- Summit Therapeutics share price is 19.00 while SMMT 8-day exponential moving average is 19.20, which is a Sell signal.
- The stock price of SMMT is 19.00 while Summit Therapeutics 20-day EMA is 19.73, which makes it a Sell.
- Summit Therapeutics 50-day exponential moving average is 19.28 while SMMT share price is 19.00, making it a Sell technically.
- SMMT stock price is 19.00 and Summit Therapeutics 200-day simple moving average is 12.70, creating a Buy signal.
Fundamental Analysis of Summit Therapeutics
Is Summit Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.30 per share, and a decrease next year of $0.08 per share.
Technical Analysis of Summit Therapeutics
Should I short Summit Therapeutics stock?
- SMMT Moving Average Covergence Divergence (MACD) indicator is -0.38, suggesting Summit Therapeutics is a Sell
- Summit Therapeutics Relative Strength Index (RSI) is 46.02, which suggest Summit Therapeutics is oversold
- The Bollinger Bands (25) for Summit Therapeutics is (18.87 - 21.19), which suggest Summit Therapeutics is a Buy
- The Bollinger Bands (100) for Summit Therapeutics is (10.66 - 22.14), which suggest Summit Therapeutics is a Buy
* Summit Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.